🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ursodeoxycholic acid (UDCA) has been the only treatment for PBC approved by...
Status
Unknown
Location
Xijing Hosipital
Start Date
2016-01
Trial ID
NCT02823366
Treatments Being Tested
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fe...
Status
Recruiting
Location
Xijing hospital
Start Date
2024-01-30
Trial ID
NCT06755541
Treatments Being Tested
Current treatment guidelines recommend ursodeoxycholic acid (UDCA) as the f...
Status
Recruiting
Location
The second hospital of Lanzhou University
Start Date
2023-02-22
Trial ID
NCT05751967
Treatments Being Tested
The purpose of this protocol is to conduct a trial in a selected population...
Status
Withdrawn
Location
Beijing 302 hospital
Start Date
2016-01
Trial ID
NCT02965911
Treatments Being Tested
Ursodeoxycholic acid (UDCA) has been the only treatment for primary biliary...
Status
Completed
Location
Xijing Hosipital
Start Date
2016-04-08
Trial ID
NCT02823353
Treatments Being Tested
The main objectives of the study were to assess the effects of fenofibrate ...
Status
Active Not Recruiting
Location
The second hospital of Lanzhou University
Start Date
2023-08-21
Trial ID
NCT06174402
Treatments Being Tested
The purpose of this study is to determine if the combination of ursodeoxych...
Status
Withdrawn
Location
University of Miami
Start Date
2011-04
Trial ID
NCT01141296
Treatments Being Tested
The main objectives of the study were to assess the effects of fenofibrate ...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2023-02-17
Trial ID
NCT05749822
Treatments Being Tested
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fe...
Status
Recruiting
Location
Xijing hospital
Start Date
2024-01-17
Trial ID
NCT06755151
Treatments Being Tested